Chronic exposure to CS2 produces morphological changes in the distal regions of long myelinated fibers characterized by perinodal accumulation of neurofilaments in axonal swellings. CS2 has also been reported to bind neuronal proteins in vivo and covalently crosslink bovine serum albumin in vitro. In this study, male Sprague-Dawley rats were exposed to 50, 100, or 200 ppm CS2 via inhalation 12h/day for 140 consecutive days. 24h following the end of treatment, animals were sacrificed and cytoskeletal proteins were isolated from spinal cords of individual animals. Proteins were resolved by SDSPAGE and stained with Coomassie Blue, or transferred to nitrocellulose and probed with monoclonal antisera against NF200, 160 and 68kD. We observed a significant decrease in the intensity of protein staining and immunoreactivity of all three NF protein bands as well as decreased immunoreactive breakdown products in animals exposed to 200 ppm CS2. A dose dependent increase in the appearance of multiple bands migrating between 260 and 400 kD with immunoreactivity against NF 160 and NF68 antibodies was also observed. The relative increase in immunoreactivity against the proteins with increasing levels of exposure was NFI6Q>NF68. These results suggest that CS2 induced cross linking of NF proteins may be involved in the aggregation of NFcharacteristic of this neuropathy.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.